Type 1 and type 2 diabetes are a cumulative risk factor for both morbidity and mortality from COVID-19 [1]. Luckily, most children with type 1 diabetes and COVID-19 have only mild symptoms or no symptoms at all [1], and children with type 1 diabetes infected with SARS-CoV-2 appear to have similar disease outcomes to peers without diabetes. However, children with COVID-19 with or without underlying conditions can develop

A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes

Maffeis, Claudio
2022-01-01

Abstract

Type 1 and type 2 diabetes are a cumulative risk factor for both morbidity and mortality from COVID-19 [1]. Luckily, most children with type 1 diabetes and COVID-19 have only mild symptoms or no symptoms at all [1], and children with type 1 diabetes infected with SARS-CoV-2 appear to have similar disease outcomes to peers without diabetes. However, children with COVID-19 with or without underlying conditions can develop
2022
Adolescents
COVID-19
Children
Type 1 diabetes
Vaccination
Vaccine
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1085629
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact